Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 12/20 | 0.71 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.63 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.47 |
| ▸ | ITGAM | P11215 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6995730 | 1.00 | MIF (0.71) | MIFITGB3ITGA2BHDAC6ALDH1A1 | |
| SCHEMBL7214876 | 1.00 | MIF (0.71) | MIFITGB3ITGA2BHDAC6ALDH1A1 | |
| SCHEMBL1535896 | 0.83 | MIF (1.00) | MIFHDAC6 | |
| SCHEMBL668842 | 0.83 | MIF (1.00) | MIFHDAC6 | |
| SCHEMBL667932 | 0.83 | MIF (1.00) | MIFHDAC6 | |
| SCHEMBL5662697 | 0.83 | ALDH1A1 (0.48) | MIFITGB3ITGA2BHDAC6ALDH1A1 | |
| Vgx-1027 SCHEMBL1404343 | 0.83 | MIF (0.78) | MIFITGB3ITGA2BHDAC6ALDH1A1 | |
| Vgx-1027 SCHEMBL1414048 | 0.83 | MIF (0.78) | MIFITGB3ITGA2BHDAC6ALDH1A1 | |
| SCHEMBL12556024 | 0.82 | MIF (0.76) | MIFITGB3ITGA2BHDAC6 | |
| SCHEMBL8250520 | 0.81 | ALDH1A1 (0.46) | MIFHDAC6ALDH1A1MAPK10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0832077-B1 | IMPROVED ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS | DU PONT PHARM CO (US) | 2001-11-14 | — | — | EP | disclosed |
| US-6306886-B1 | SOLID POLYMORPH ANTICOAGULANTS | DUPONT PHARMACEUTICALS COMPANY | 2001-10-23 | — | — | US | disclosed |
| US-6265400-B1 | ANTICOAGULANTS | DUPONT PHARMACEUTICALS COMPANY | 2001-07-24 | — | — | US | disclosed |
| EP-0730590-B1 | ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | DU PONT PHARM CO (US) | 2001-01-17 | — | — | EP | disclosed |
| US-6114328-A | ANTICOAGULANTS; BLOOD DISORDERS | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-09-05 | — | — | US | disclosed |
| EP-0970950-A2 | Novel isoxazoline and isoxazole fibrinogen receptor antagonists | DuPont Pharmaceuticals Company (US) | 2000-01-12 | — | — | EP | disclosed |
| US-5849736-A | Isoxazoline and isoxazole fibrinogen receptor antagonists | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-12-15 | — | — | US | disclosed |
| US-5811441-A | INHIBITION OF PLATELET AGGREGATION; TREATMENT OF AUTOIMMUNE DISEASES | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-09-22 | — | — | US | disclosed |
| WO-1996038426-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-12-05 | — | — | WO | disclosed |
| EP-0730590-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995014683-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-06-01 | — | — | WO | disclosed |